Neonc Technologies Holdings (NTHI) Net Cash Flow (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Net Cash Flow of $79872.0 for Q1 2026, down 98.51% year-over-year from $5.4 million in Q1 2025, and up 108.37% quarter-over-quarter from -$954495.0 in Q4 2025.
Neonc Technologies Holdings (NTHI) Net Cash Flow (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Net Cash Flow for 3 consecutive years, with $79872.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 98.51% year-over-year to $79872.0; the TTM figure through Mar 2026 stood at -$4.8 million (down 188.34% YoY), while the FY2025 annual figure was -$6164.0, down 118.66% from the prior year.
- Net Cash Flow climbed to $79872.0 in Q1 2026 per NTHI's latest filing, from -$954495.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $5.4 million in Q1 2025 and bottomed at -$5.3 million in Q2 2025.
- Historically, Net Cash Flow has averaged $67415.4 across 3 years, with a median of -$26848.0 in 2024.
- On a YoY basis, Net Cash Flow climbed as much as 20117.57% in 2025 and fell as far as 447.9% in 2025.
- Neonc Technologies Holdings' Net Cash Flow stood at -$1.3 million in 2024, then increased by 24.83% to -$954495.0 in 2025, then jumped by 108.37% to $79872.0 in 2026.
- Business Quant data shows NTHI's Net Cash Flow at $79872.0 in Q1 2026, -$954495.0 in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | 1.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.83 Mn |
| Jun 30, 2026 | 1.83 Mn |
| Mar 31, 2026 | 79,872.00 |
| Mar 31, 2026 | 79,872.00 |
| Dec 31, 2025 | -954,495.00 |
| Dec 31, 2025 | -954,495.00 |
| Sep 30, 2025 | 1.39 Mn |
| Sep 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | -5.31 Mn |
| Jun 30, 2025 | -5.31 Mn |
| Mar 31, 2025 | 5.37 Mn |
| Mar 31, 2025 | 5.37 Mn |
| Dec 31, 2024 | -1.27 Mn |
| Dec 31, 2024 | -1.27 Mn |
| Sep 30, 2024 | -197,907.00 |
| Sep 30, 2024 | -197,907.00 |
| Jun 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | -26,848.00 |
| Mar 31, 2024 | -26,848.00 |